NEFL and amyotrophic lateral sclerosis: The pre-treatment plasma NfL levels observed in CLN2 disease patients is at the high end of neurological disease levels – similar to that seen in ALS, FTD/ALS, HIV-associated dementia and higher than many other neurodegenerative diseases.